Cytodyn Inc (CYDY)

[stockorus]

Basically the claim is that we have lost the competitive edge in both HIV and NASH, hence essentially can't bring LL to the market based on our present results in them. That leaves us with Covid hope and Cancer; and even in cancer, the previous trial as I recall did not show us as sufficiently superior to the current SOC.

Longs need to respond to and counter these assertions if you believe otherwise, that our drug still has a good chance of getting approval for these indications.